Hwei-Chung Wang

880 total citations
15 papers, 138 citations indexed

About

Hwei-Chung Wang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Hwei-Chung Wang has authored 15 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Hwei-Chung Wang's work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). Hwei-Chung Wang is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). Hwei-Chung Wang collaborates with scholars based in Taiwan, United Kingdom and United States. Hwei-Chung Wang's co-authors include Su-Shun Lo, Wing‐Yiu Lui, Cheng‐Hsi Su, Yi‐Ming Shyr, Dar‐Ren Chen, DA-TIAN BAU, King‐Jen Chang, Liang‐Chih Liu, Chia-Wen Tsai and Cheng‐Chieh Lin and has published in prestigious journals such as BMJ Open, Surgery and BMC Cancer.

In The Last Decade

Hwei-Chung Wang

14 papers receiving 136 citations

Peers

Hwei-Chung Wang
Comparison fields: 5 of 43
  • Oncology 71
  • Molecular Biology 47
  • Cancer Research 41
  • Pulmonary and Respiratory Medicine 33
  • Surgery 31
Replace Lupe Sanchez-Mete with:
Lupe Sanchez-Mete Italy
Lonneke W. Kessels Netherlands
Abirami Sivapiragasam United States
László Landherr Hungary
Elisabeth Melbinger‐Zeinitzer Austria
G. Koumakis Greece
J. P. Jordaan South Africa
Giorgio Bonciarelli Italy
Petra Jankowska United Kingdom
Lupe Sanchez-Mete Italy View profile →
Citations per field, relative to Hwei-Chung Wang
Hwei-Chung Wang · 1×
Citations per year, relative to Hwei-Chung Wang
Hwei-Chung Wang · 1×

Countries citing papers authored by Hwei-Chung Wang

Since Specialization
Citations

This map shows the geographic impact of Hwei-Chung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwei-Chung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwei-Chung Wang more than expected).

Fields of papers citing papers by Hwei-Chung Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hwei-Chung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwei-Chung Wang. The network helps show where Hwei-Chung Wang may publish in the future.

Co-authorship network of co-authors of Hwei-Chung Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hwei-Chung Wang. A scholar is included among the top collaborators of Hwei-Chung Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hwei-Chung Wang. Hwei-Chung Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Work Indexed citations
1 0
2 6
3 12
4 2
5
Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer.
7
6 26
7 11
8
Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
23
9 9
10 4
11
Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer.
7
12 6
13
Pseudomyxoma peritonei: does a true mucolytic agent exist? In vitro and in vivo studies.
9
14
Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
5
15
Comparison of resectable and unresectable periampullary carcinomas.
11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026